Liposomal Doxorubicin Market Drivers, Product Outlook and Revenue Analysis till 2024

Liposomal Doxorubicin Market Drivers, Product
Outlook and Revenue Analysis till 2024
“The drivers for liposomal doxorubicin market include rise in ovarian and breast cancer coupled with increasing
awareness for liposomal doxorubicin formulation.”
The Global Liposomal Doxorubicin Market is projected to witness a higher CAGR during the forecast period.
Liposomal anthracyclines lessen the risk of heart disease when compared to the usual doxorubicin while maintaining
the anti-tumor capabilities. Liposomal doxorubicin formulations comprise liposomal doxorubicin blended with the
peglyated liposomal doxorubicin. Simply put, peglyation is a process comprising doxorubicin wrapped under a PED
layer. Peglyation hence protects liposomes from mononuclear phagocyte system.
The drivers for liposomal doxorubicin market include rise in ovarian and breast cancer coupled with increasing
awareness for liposomal doxorubicin formulation. Rise in use of drug formulation for ovarian treatment contributes
to the market growth during the forecast period. WHO estimates a rise in cancer by 40% by next two decades, which
implies the need for better treatment and demand for advanced doxorubicin with liposomal formulation. Rise in
geriatric population fuels the market demand coupled with rise in number of approvals for generic formulations.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/liposomal-doxorubicin-market
By formulation, the market segmentation includes powder and solution. By cancer type, the market is segmented as
prostate cancer, breast cancer, lung cancer, ovary cancer, bladder cancer, stomach cancer and Leukemia. By
distribution channel, the liposomal doxorubicin market includes retail pharmacies, hospital pharmacy and e-
commerce. Product segment includes J&J, Sun Pharma and Teva. Application category includes ovarian, breast,
kidney cancer, multiple myeloma and kaposi sarcoma.
Geographical segmentation for liposomal doxorubicin market include North America, South America, Europe, Asia-
Pacific, Europe, Middle East and Africa. North America dominates the market growth during the forecast period owing
to high prevalence of breast, liver and ovarian cancers. Asia-Pacific market is highly anticipated to enjoy a steady
growth in the forecast period. The key players in the liposomal doxorubicin industry include Johnson & Johson,
Mercek & Co, CiplaInc, SRS Pharmaceuticals Inc and Cadila Pharmaceuticals.

Request Sample Copy of This Report @
https://www.millioninsights.com/industry-reports/liposomal-doxorubicin-market/request-sample
Market Segment:
Liposomal Doxorubicin Product outlook (Market revenue in USD Million, 2013 - 2024)
• J&J (Doxil/Caelyx)
• Sun Pharma (Lipodox)
• Teva (Myocet)
• Others
Liposomal Doxorubicin Application Outlook (Market revenue in USD Million, 2013 - 2024)
• Ovarian Cancer
• Multiple Myeloma
• Kaposi Sarcoma
• Leukemia
• Bone Sarcoma
• Breast Cancer
• Endometrial Cancer
• Gastric Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancer
Liposomal Doxorubicin Regional Outlook (Market Revenue in USD Million, 2013 - 2024)
• North America
• U.S.

• Canada
• Europe
• UK
• Germany
• Asia Pacific
• Japan
• China
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa
See More Reports of This Category by Million Insights @
https://www.millioninsights.com/industry/pharmaceuticals

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9
Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand
Galleria, Model Colony, Shivaji Nagar,
Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
Visit Our Blog: www.millioninsights.blogspot.com